[{"address1": "5959 Horton Street", "address2": "7th Floor", "city": "EmeryVille", "state": "CA", "zip": "94608", "country": "United States", "phone": "510 871 4880", "website": "https://metagenomi.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Metagenomi Therapeutics, Inc. a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in EmeryVille, California.", "fullTimeEmployees": 124, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jian  Irish M.B.A., Ph.D.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 734626, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brian Charles Thomas Ph.D.", "age": 56, "title": "Co-Founder & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 913299, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pamela M. Wapnick M.B.A.", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 581813, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph  Knowles M.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Leonard", "title": "Senior Vice Pres\u00adi\u00addent of Tech\u00adni\u00adcal Devel\u00adop\u00adment & Oper\u00ada\u00adtions", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew L. Wein J.D.", "age": 53, "title": "Gen\u00ader\u00adal Coun\u00adsel, Com\u00adpli\u00adance Offi\u00adcer, Head of BD&L and Cor\u00adpo\u00adrate Secretary", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Brooks Ph.D.", "age": 59, "title": "Senior Vice President of Research", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Katalin  Kauser M.D., Ph.D.", "title": "Senior Vice Pres\u00adi\u00addent of Trans\u00adla\u00adtion\u00adal Biol\u00ado\u00adgy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.45, "open": 1.47, "dayLow": 1.45, "dayHigh": 1.505, "regularMarketPreviousClose": 1.45, "regularMarketOpen": 1.47, "regularMarketDayLow": 1.45, "regularMarketDayHigh": 1.505, "payoutRatio": 0.0, "beta": 0.521, "forwardPE": -0.8, "volume": 198265, "regularMarketVolume": 198265, "averageVolume": 327075, "averageVolume10days": 308590, "averageDailyVolume10Day": 308590, "bid": 1.42, "ask": 1.51, "bidSize": 1, "askSize": 1, "marketCap": 54818260, "fiftyTwoWeekLow": 1.23, "fiftyTwoWeekHigh": 3.95, "allTimeHigh": 12.74, "allTimeLow": 1.23, "priceToSalesTrailing12Months": 1.7733077, "fiftyDayAverage": 1.6602, "twoHundredDayAverage": 1.9181, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -87632744, "profitMargins": -2.8705702, "floatShares": 27252934, "sharesOutstanding": 37546751, "sharesShort": 2423284, "sharesShortPriorMonth": 2208088, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0645, "heldPercentInsiders": 0.29292, "heldPercentInstitutions": 0.18019, "shortRatio": 8.72, "shortPercentOfFloat": 0.088599995, "impliedSharesOutstanding": 37546751, "bookValue": 4.753, "priceToBook": 0.30717444, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -88738000, "trailingEps": -2.39, "forwardEps": -1.825, "enterpriseToRevenue": -2.835, "enterpriseToEbitda": 1.01, "52WeekChange": -0.3865546, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 1.46, "targetHighPrice": 12.0, "targetLowPrice": 7.0, "targetMeanPrice": 9.33333, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 184114000, "totalCashPerShare": 4.904, "ebitda": -86791000, "totalDebt": 41663000, "quickRatio": 6.3, "currentRatio": 6.417, "totalRevenue": 30913000, "debtToEquity": 23.348, "revenuePerShare": 0.831, "returnOnAssets": -0.19023001, "returnOnEquity": -0.40872002, "grossProfits": -65183000, "freeCashflow": -55426124, "operatingCashflow": -91622000, "revenueGrowth": -0.248, "grossMargins": -2.1086, "ebitdaMargins": -2.80759, "operatingMargins": -2.6376002, "financialCurrency": "USD", "symbol": "MGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "averageDailyVolume3Month": 327075, "fiftyTwoWeekLowChange": 0.23000002, "fiftyTwoWeekLowChangePercent": 0.18699189, "fiftyTwoWeekRange": "1.23 - 3.95", "fiftyTwoWeekHighChange": -2.49, "fiftyTwoWeekHighChangePercent": -0.63037974, "fiftyTwoWeekChangePercent": -38.65546, "earningsTimestampStart": 1755115200, "earningsTimestampEnd": 1755115200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.39, "epsForward": -1.825, "epsCurrentYear": -2.3375, "priceEpsCurrentYear": -0.6245989, "fiftyDayAverageChange": -0.20019996, "fiftyDayAverageChangePercent": -0.120587856, "twoHundredDayAverageChange": -0.45809996, "twoHundredDayAverageChangePercent": -0.23883007, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-02-09", "cryptoTradeable": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1707489000000, "postMarketChangePercent": -0.68493086, "postMarketPrice": 1.45, "postMarketChange": -0.00999999, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.45 - 1.505", "fullExchangeName": "NasdaqGS", "corporateActions": [], "postMarketTime": 1771018948, "regularMarketTime": 1771016402, "exchange": "NMS", "messageBoardId": "finmb_633445224", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.689654, "regularMarketPrice": 1.46, "shortName": "Metagenomi Therapeutics, Inc.", "longName": "Metagenomi Therapeutics, Inc.", "displayName": "Metagenomi Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]